Skip to content
  • About Us
  • Pipeline
  • Publications
  • Careers
  • Investors
  • Careers
  • Publications

    Therapeutic potential of a HER3 antibody-drug conjugate for the treatment of HER3-expressing cancers

    April 8, 2024April 8, 2024
    Posters & Oral Presentations
    by Elevation Oncology

    Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

    Presenting Author: Thomas O’Hare

    Save the Document
    Download PDF
    Share
    Other Related Resources
    April 27, 2025April 29, 2025

    Posters & Oral Presentations

    Preclinical discovery and characterization of EO-1022, a site-specific glycan-conjugated anti-HER3 vcMMAE ADC for treating solid tumors Read More
    Publications
    • Pipeline
    • About Us
    • Careers
    • Contact
    • Investors
    • Terms
    • Privacy